Current Clinical Trials in Alzheimer’s Research
by Michael Jorrin, "Doc Gumshoe" | September 26, 2013 12:09 pm
Doc Gumshoe Looks at a few promising trials in Alzheimer's Disease drugs
This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.
Source URL: https://www.stockgumshoe.com/2013/09/microblog-current-clinical-trials-in-alzheimers-research/
Did you look at STSI? They have an AD clinical trial expected completion Feb 2014. See:
http://www.clinicaltrials.gov/ct2/show/NCT01669876?term=anatabine&rank=4
Thanks for all the non advice on what to buy in the biotech industry. I’m sure you have stayed well within the bounds of your disclaimers. Seriously, I appreciate the reviews that may well have taken uncounted hours or excellent resources to piece together. I have gotten over excited on some losing stocks before.
When you have time, you might take a look at ESPH. This stock has gone through a long up hill battle trying to break through the wall of chemical companies’ strangle hold on clean water technology and how to save the planet by dumping chemicals on any great problem that exists on land or sea (viz. the Discovery disaster in the Gulf). Jean Michel Cousteau has placed this high on his list of companies that can use clean water in many industries and well as remove the pollutants created by industries. I think that recently all their awards and modest success deserves some serious attention in spite of their low stock pricing.
So far I am very happy with Biotech firm that feature in stock gumshoes earlier (ALNY).
I bought the first one on July 2 at $32 now as of today it about $63.44 52 weeks high a few days ago close to $65. I then decide to join the club. Probably won’t have any more biotech anymore. I am really happy with ALNY . Quite a home run after I bought it.
I read a lot of article from stock gumshoes but only few that I bought after do more research on my own after that. Only 2 stocks that I know and bought by reading at stock gumshoes. Another one is BOFI and happens to be good one also. Good to be Lucky than good. Thanks stock gumshoes.
Regarding STSI which pertains to anatabine and Anatabloc sold at GNC. I am completely biased because I have been on Anatabloc since August 2012 and it has completely
changed my life for the positive. Anatabine is a potent anti-inflammatory nutraceutical derived from plants with no side effects. Anatabloc works on reducing and modulating inflammation throughout the entire body.
http://www.youtube.com/watch?v=N3XwkBX1WN0&feature=youtu.be
Dr. Ryan Lanier “Scientifically proven to manage excessive inflammation”
Product Reviews by Customers
http://www.gnc.com/product/index.jsp?productId=18604176&kwCatId=#showReviews
http://www.gnc.com/product/index.jsp?productId=18604166&kwCatId=#showReviews
CEREBRAL PALSY http://anatabloc.com/2013/05/marty-gregoire-an-inspiring-individual-with-a-story-to-tell/
Can Anatabloc Successfully Treat Alzheimer’s?
Dr. Michael Mullan, M.D., Ph.D., President and CEO of the Roskamp Institute, commented: “We have known for a long time that Alzheimer’s disease has a large inflammatory component. We also have observed the anti-inflammatory effects of anatabine (the active ingredient of Anatabloc) in laboratory tests which is why we anticipate evidence of anti-inflammatory effects in this population.”
Scientists Establish Link Between Inflammatory Process and Progression of Alzheimer’s Disease
http://www.sciencedaily.com/releases/2012/12/121219133336.htm
What to do, to reduce the risk of Alzheimer’s Disease? SEE http://lnkd.in/hte5Zk
Anatabine=Anatabloc supplement GNC
Brain inflammation Alzheimer http://bit.ly/Tk1Wxn
Dr. Michael Mullan, the CEO and President of the Roskamp Institute stated, “Anatabine continues to demonstrate widespread anti-inflammatory properties in a broad array of pre-clinical models. Given the commonality of inflammatory systems in rodents and humans, there’s much reason to expect that anatabine will demonstrate similar properties in humans. In fact, the team went on to demonstrate that in human blood inflamed with LPS, the presence of anatabine dramatically dampened the inflammatory response, a result also included in the paper.”
A New Look at Brain Inflammation in Alzheimer’s
http://www.dana.org/news/features/detail.aspx?id=40308
STSI has a AD clinical trial expected completion Feb 2014. See:
http://www.clinicaltrials.gov/ct2/show/NCT01669876?term=anatabine&rank=4
How could leave out Anavex.. It’s the only company working on a cure, not just treating the symptoms. It’s in Phase 2 and VG phase 1 results..
I really appreciate this writeup. As a son who just put his AD stricken mother away into a nursing home in July, I search daily for any/all relevant information on this awful disease. Great job and much, much thanks.
Bill V
Along with Bill V., am grateful for the clinical rundowns, since I’m dealing with 2 family members suffering from Alzheimer’s. Perhaps this article should be posted on Alzheimer’s
support blogs and distributed to a wider audience that can benefit from this information,
over and above the investment ideas. Thank you!! for curating this valuable information